Doctor Sakis Themistoclakis

Doctor Sakis Themistoclakis

Hospital of the Angelo Mestre, Venice (Italy)

Member of:

Dr. Themistoclakis is the Director of Cardiology of Dell'Angelo Hospital in Venice-Mestre, Italy. His main expertise in in the Electrophysiology field. He is a member of the following scientific societies: EHRA, ESC, Italian Federation of Cardiology (IFC), ANMCO and AIAC. Within the Italian Society of Arrhythmology and Cardiac Pacing (AIAC), was appointed General Secretary and co-chair of the AIAC Working Group for Catheter Ablation from April 2008 to April 2010; he was then AIAC's Vice-President, (April 2010- March 2012). Currently, he is a regional past-president of ANMCO Veneto and member of national executive board. Dr. Themistoclakis has involved as board member of national and international guidelines or consensus document on Arrhythmias. He has participated as Chairman and/or Speaker to several international meetings on cardiac arrhythmias and has authored or co-authored more than 200 publications, among book chapters, international journals, and abstracts.

Presentations Articles

Safety and efficacy of oral anticoagulation discontinuation in high thromboembolic risk patients at long term follow-up after successful atrial fibrillation ablation

Event: ESC Congress 2019

Topic: Catheter Ablation of Arrhythmias

Session: Atrial fibrillation ablation - Results from large cohorts

Access

Anticoagulation can be stopped after successful catheter ablation of AF in patients with CHADSVASC ≥2 risk of thromboembolism- PRO

Event: EHRA 2018

Topic: Stroke Prevention in Cardioversion

Session: Tough decisions in anticoagulation in atrial fibrillation

Access

In-vivo lesion index (LSI) validation in percutaneous radiofrequency catheter ablation

Event: EHRA 2018

Topic: Catheter Ablation of Arrhythmias

Session: Ventricular tachycardia

Access

From remote monitoring to patient engagement: latest innovations.

Event: EHRA EUROPACE - CARDIOSTIM 2017

Topic: Remote monitoring

Session: Latest developments in pacemaker therapy

Access

Doctor Sakis Themistoclakis

Biography

Contributor content

Safety and efficacy of oral anticoagulation discontinuation in high thromboembolic risk patients at long term follow-up after successful atrial fibrillation ablation

Anticoagulation can be stopped after successful catheter ablation of AF in patients with CHADSVASC ≥2 risk of thromboembolism- PRO

In-vivo lesion index (LSI) validation in percutaneous radiofrequency catheter ablation

From remote monitoring to patient engagement: latest innovations.

ESC 365 is supported by